Search Results - "MASCARENHAS, Daniel A. N"

Refine Results
  1. 1

    Reuse of Explanted, Resterilized Implantable Cardioverter-Defibrillators: A Cohort Study by PAVRI, Behzad B, LOKHANDWALA, Yash, KULKARNI, Gaurav V, SHAH, Mandar, KANTHARIA, Bharat K, MASCARENHAS, Daniel A. N

    Published in Annals of internal medicine (16-10-2012)
    “…Implantable cardioverter-defibrillators (ICDs) often have clinically useful battery life remaining when explanted because of upgrades, infection, or patient…”
    Get full text
    Journal Article
  2. 2

    Reuse of Explanted Permanent Pacemakers Donated by Funeral Homes by Kantharia, Bharat K., MD, Patel, Sandeep S., MD, Kulkarni, Gaurav, MBBS, Shah, Arti N., MD, Lokhandwala, Yash, MD, Mascarenhas, Erica, Mascarenhas, Daniel A.N., MD

    Published in The American journal of cardiology (15-01-2012)
    “…Poor patients in developing countries may not receive permanent pacemakers (PPMs) even as lifesaving measures because of their high cost. In this report we…”
    Get full text
    Journal Article
  3. 3

    Outpatient initiation of dofetilide: insights from the complexities of atrial fibrillation management during the COVID-19 lockdown by Mascarenhas, Daniel A. N., Mudumbi, Praveen C., Kantharia, Bharat K.

    “…Background At peak COVID-19 lockdown, patients with symptomatic atrial fibrillation (AF) were faced with an equipoise between a palliative rate-control versus…”
    Get full text
    Journal Article
  4. 4

    Ticagrelor Associated Heart Block: The Need for Close and Continued Monitoring by Sharma, Munish, Mascarenhas, Daniel A. N.

    Published in Case reports in cardiology (01-01-2017)
    “…Ticagrelor is an antiplatelet agent prescribed to prevent the development of adverse cardiac events after acute coronary syndrome (ACS). According to the PLATO…”
    Get full text
    Journal Article
  5. 5

    Outpatient Initiation of Sotalol in Patients with Atrial Fibrillation: Utility of Cardiac Implantable Electronic Devices for Therapy Monitoring by Mascarenhas, Daniel A. N., Mudumbi, Praveen C., Kantharia, Bharat K.

    “…Background Antiarrhythmic drugs are often used in the management of patients with atrial fibrillation (AF). Sotalol is conventionally initiated in the…”
    Get full text
    Journal Article
  6. 6

    Role of cardiovascular implantable electronic devices in delivering individualized disease-guided management of patients with non-valvular atrial fibrillation and high bleeding risk by Mascarenhas, Daniel A. N., Sharma, Munish, Ziegler, Paul D., Kantharia, Bharat K.

    Published in Acta Cardiologica (04-03-2019)
    “…Background: Many patients with non-valvular atrial fibrillation (NVAF) with high risk for thromboembolic stroke and bleeding may not wish to continue long-term…”
    Get full text
    Journal Article
  7. 7

    Role of insertable cardiac monitors in anticoagulation therapy in patients with atrial fibrillation at high risk of bleeding by Mascarenhas, Daniel A N, Farooq, Mohammad U, Ziegler, Paul D, Kantharia, Bharat K

    Published in Europace (London, England) (01-06-2016)
    “…We aimed to ascertain whether an insertable cardiac monitor (ICM)-guided rhythm-control strategy and assessment of atrial fibrillation (AF) burden may allow…”
    Get full text
    Journal Article
  8. 8

    Conversion of Atrial Fibrillation to Sinus Rhythm During Coronary Intervention: Complex Interplay of Arrhythmic and Ischemic Substrate by Sharma, Munish, Mascarenhas, Daniel A N, Kantharia, Bharat

    Published in Cardiology research (01-02-2018)
    “…Atrial fibrillation (AF) can be a manifestation of acute coronary syndrome (ACS). Presence of AF during ACS further adds to complexities in the management…”
    Get full text
    Journal Article
  9. 9

    Is There Always a Need for Permanent Pacemaker Replacement After Device Infection? A Tale of Two Patients by Sharma, Munish, Mascarenhas, Daniel A N

    Published in Cardiology research (01-04-2018)
    “…There has been an increase in number of cardiac implantable electronic devices (CIEDs) implantation and with this we have witnessed increased rates of CIED…”
    Get full text
    Journal Article
  10. 10

    Do All Patients with Atrial Fibrillation Need Long-Term Anticoagulation? by Sharma, Munish, Masih, Rohit, Mascarenhas, Daniel A. N.

    Published in Clinics and practice (31-07-2017)
    “…Atrial fibrillation (AF) is the most common cardiac arrhythmia worldwide with an estimated number of 2.7-6.1 million cases in the United States (US) alone. The…”
    Get full text
    Journal Article
  11. 11

    Do All Critical Aortic Stenosis with Chest Pain Need Aortic Valve Replacement? A Case Report by Sharma, Munish, Mascarenhas, Daniel A. N.

    Published in Clinics and practice (24-11-2016)
    “…Aortic valve replacement (AVR) remains the cornerstone of treatment for symptomatic critical aortic stenosis (AS). It is a Class I indication that symptomatic…”
    Get full text
    Journal Article
  12. 12

    Intracoronary abciximab use in patients undergoing PCI at a community hospital: a single operator experience by Patel, Sandeep S, Rana, Hiralal, Mascarenhas, Daniel A N

    “…To evaluate the safety of intracoronary (IC) abciximab during percutaneous coronary intervention (PCI). Adjunctive treatment with glycoprotein IIb/IIIa…”
    Get more information
    Journal Article
  13. 13

    Dofetilde and flecainide combination: the serendipity of successful treatment of atrial fibrillation after failed ablation by Mascarenhas, Daniel.A.N., Kantharia, Bharat K.

    Published in Canadian journal of cardiology (14-11-2024)
    “…Antiarrhythmic drugs (AADs) and catheter ablation (CA) are guideline-directed rhythm control treatment for atrial fibrillation (AF). AADs are rarely used in…”
    Get full text
    Journal Article
  14. 14

    Idiopathic cardiac asystole presenting as epileptic seizures by Gavris, Mihai F., Khalighi, Koroush, Mascarenhas, Daniel A.N.

    Published in Journal of electrocardiology (01-07-2002)
    “…Cardiac asystole has been associated with partial or generalized seizures (anoxic seizure) but, despite the previous descriptions, is still an underdiagnosed…”
    Get full text
    Journal Article
  15. 15

    Revisiting the Role of Antiarrhythmic Drugs in Prevention of Atrial Fibrillation Recurrence: A Single Center Retrospective Review by Mascarenhas, Daniel An, Sharma, Munish

    Published in Cardiology research (01-06-2018)
    “…We conducted a retrospective analysis to revisit the efficacy of four different commonly used antiarrhythmic drugs (AADs) in a single community hospital…”
    Get full text
    Journal Article
  16. 16

    A Community Level Sample Survey to Determine CurrentUnderstanding About Medical Recycling of Cardiovascular ImplantableElectronic Devices by Mahesh, Milan, Sharma, Munish, Mascarenhas, Daniel An

    Published in Cardiology research (01-08-2018)
    “…Medical recycling and reutilization of cardiovascular implantableelectronic devices (CIEDs) have a significant impact not only in patientsof low-income…”
    Get full text
    Journal Article
  17. 17

    Role of insertable cardiac monitors in anticoagulation therapy in patients with atrial fibrillation at high risk of bleeding super() by Mascarenhas, Daniel AN, Farooq, Mohammad U, Ziegler, Paul D, Kantharia, Bharat K

    Published in Europace (London, England) (01-06-2016)
    “…Aims We aimed to ascertain whether an insertable cardiac monitor (ICM)-guided rhythm-control strategy and assessment of atrial fibrillation (AF) burden may…”
    Get full text
    Journal Article
  18. 18
  19. 19
  20. 20